AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Outset Medical Inc. (OM)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

0.95

0.01 (1.06%)

At close: Feb 20, 2025, 3:59 PM

0.95

0.00%

After-hours: Feb 20, 2025, 06:23 PM EST

undefined% (undefined)

Bid	0.92
Market Cap	51.02M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-2.74
PE Ratio (ttm)	-0.35
Forward PE	n/a
Analyst	Buy

Ask	0.96
Volume	3,420,488
Avg. Volume (20D)	1,067,108
Open	0.97
Previous Close	0.94
Day's Range	0.83 - 1.08
52-Week Range	0.43 - 5.22
Beta	undefined

About OM

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015...

[Show more]

Industry Medical - Devices

Sector Healthcare

IPO Date Sep 15, 2020

Employees 480

Stock Exchange NASDAQ

Ticker Symbol OM

Website https://www.outsetmedical.com

Full Company Profile

Analyst Forecast

According to 3 analyst ratings, the average rating for OM stock is "Buy." The 12-month stock price forecast is $3, which is an increase of 215.79% from the latest price.

Buy 66.67%

Hold 33.33%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Outset Medical Inc. is scheduled to release its earnings on May 7, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

3 months ago

+25.18%

Outset Medical shares are trading higher after the... Unlock content with Pro Subscription

6 months ago

-68.53%

Outset Medical shares are trading lower after the company reported worse-than-expected Q2 financial results and cut its FY24 revenue guidance.

News

1 day ago · seekingalpha.com

Outset Medical, Inc. (OM) Q4 2024 Earnings Call Transcript

Outset Medical, Inc. (NASDAQ:OM ) Q4 2024 Earnings Conference Call February 19, 2025 5:00 PM ET Company Participants Jim Mazzola - Head of Investor Relations Leslie Trigg - Chair and CEO Nabeel Ahmed ...

1 day ago · fool.com

Outset Medical: Profitability Path Brightens

Outset Medical (OM 3.52%), the innovator behind the Tablo Hemodialysis System, reported fourth-quarter earnings on Wednesday, Feb. 19, that topped analysts' consensus expectations on top and bottom li...

1 day ago · zacks.com

Outset Medical, Inc. (OM) Reports Q4 Loss, Tops Revenue Estimates

Outset Medical, Inc. (OM) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to loss of $0.59 per share a year ago.

1 week ago · zacks.com

Outset Medical, Inc. (OM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Outset Medical (OM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.